84418-31-5

Upstream product

• 2007-16-1 (RS)-1-bromo-3-(1-naphthyloxy)-2-propanol 
• 5080-22-8 N-isopropylhydroxyamine 
• 525-66-6 propranolol 

Relevant academic research and scientific papers

Comparative study on degradation of propranolol and formation of oxidation products by UV/H2O2 and UV/persulfate (PDS)

The frequent detection of propranolol, a widely used β-blocker, in wastewater effluents and surface waters has raised serious concern, due to its adverse effects on organisms. UV/hydrogen peroxide (UV/H2O2) and UV/persulfate (UV/PDS) processes are efficient in eliminating propranolol in various waters, but the formation of oxidation products in these processes, as well as the assessment of their toxicity, has not been systematically addressed. In this study, we identified and compared transformation products of propranolol produced by hydroxyl radical (?OH) and sulfate radical (SO4?-). The electrostatic attraction enhances the reaction between SO4?- and the protonated form of propranolol, while ?OH shows non-selectivity toward both protonated and neutral propranolol species. The hydroxylation of propranolol by ?OH occurs at either amine moiety or naphthalene group while SO4?- favors the oxidation of the electron-rich naphthalene group. Further oxidation by ?OH and SO4?- results in ring-opening products. Bicarbonate and chloride exert no effect on propranolol degradation. The generation of CO3?- and Cl-containing radicals is favorable to oxidizing naphthalene group. The acute toxicity assay of Vibrio fischeri suggests that SO4?- generates more toxic products than ?OH, while CO3?- and Cl-containing radicals produce similar toxicity as SO4?-. High concentrations of bicarbonate in UV/H2O2 increase the toxicity of treated solution.

Derivatives of β-adrenergic antagonists. N-nitrosopropranolol and N-hydroxypropranolol and its aldonitrone

Potential precursors to chemically reactive species derived from the β-adrenergic antagonist propranolol were synthesized and tested for mutagenicity in the Ames Salmonella assay. N-Hydroxypropranolol (1), the corresponding aldonitre, 3-(1-naphthoxy)-2-hydroxypropionaldehyde N-isopropylnitrone (2), and N-nitrosopropranolol (3) were prepared and tested. N-Hydroxypropranolol (1) was obtained by direct alkylation of 3-(1-naphthoxy)-1-bromo-2-propanol with N-isopropylhydroxylamine and isolated as its neutral oxalate or HBr salt. The aldonitrone (2) was obtained by mercuric oxide oxidation of the hydroxylamine. N-Nitrosopropranolol (3) was prepared by treating propranolol with nitrous acid. None of the compounds was mutagenic in the Ames assay with Salmonella typhimurium TA-98 and TA-100 strains, either in the absence or in the presence of the S-9 liver fraction from Arochlor 1254 treated rats. None of the compounds was significantly toxic to the bacteria, except for slight toxicity of the oxalate salt of 1.